The global retinal disorders treatment market is projected to grow at a significant CAGR of over 7% during the forecast period. The factors that are contributing to the growth of the market include the increased incidences of eye-related disorders such as various infections and allergies, diabetic eye diseases and many others. According to the WHO, in 2019, around 2.2 billion people from across the globe were suffering from one or the other kind of visual impairment and 80% of these are considered avoidable. Thus, the higher incidences and prevalence rate of any kind of eye disease create the demand for drugs for the treatment of diseases and hence significantly creating scope for the market growth. Other factors that are contributing to the market growth include the increasing geriatric population,rising R&D activities regarding the introduction of novel drugs, and the presence of strong product pipeline.

Request a Free Sample of our Global Retinal Disorders Treatment Market: https://www.omrglobal.com/request-sample/retinal-disorders-treatment-market

The global retinal disorders treatment market is segmented on the basis of disease type and dosage form. Based on the disease type, the market is segmented into floaters, macular degeneration, diabetic retinopathy, retinal detachment, among others such as retinitis pigmentosa and retinal vein occlusion. Based on the dosage form, the market is segmented into gels, eye solutions, tablets and capsules, ointments, and others.

A full Report of Global Retinal Disorders Treatment Market is Available at: https://www.omrglobal.com/industry-reports/retinal-disorders-treatment-market

Amongst the disease type, the diabetic retinopathy is projected to hold a considerable share in the market. The segmental growth is accredited to the increased cases of diabetes among the peoples. The diabetes medicines on the regular basis consumption may damage the veins in the eyes and lead to the minute blood loss through them, which causes the clots in the eye and results in the blurred or impaired vision. As per the estimation of the International Diabetes Federation (IDF) in 2018, 382 million people had diabetes globally, and this number is predicted to rise to 592 million by 2035. Increasing prevalence of diabetes will result in more number of cases of diabetic retinopathy and hence will drive the segmental growth of the market.
Global Retinal Disorders Treatment Market Segmentation

By Disease Type

• Floaters
• Macular Degeneration
• Diabetic Retinopathy
• Retinal Detachment
• Others (Retinitis Pigmentosa, Retinal Vein Occlusion)

By Drug Dosage Form

• Gels
• Eye Solutions
• Tablets and Capsules
• Ointments
• Others

Regional Analysis

• North America
• United States
• Canada
• Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
• Asia-Pacific
• China
• India
• Japan
• Rest of Asia-Pacific
• Rest of the World

Company Profiles

• Aerie Pharmaceuticals Inc.
• Allergan Plc
• Aurolab
• Bayer AG
• Boehringer IngelheimInternational GmbH
• Carl Zeiss Meditec AG
• EyePoint Pharmaceuticals, Inc.
• F. Hoffmann-La Roche Ltd.
• Genetech Inc.
• Graybug Vision Inc.
• Inflammasome Therapeutics Inc.
• KODIAK SCIENCES INC.
• Kubota Pharmaceutical Holdings Co. Ltd.
• NIDEK Co., Ltd.
• Novartis International AG
• Oxurion NV
• Pfizer Inc.
• Regeneron Pharmaceuticals Inc.
• Santen Pharmaceutical Co. Ltd.
• Takeda Pharmaceutical Co. Ltd.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/retinal-disorders-treatment-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit Orion Market Research

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 7803040404